Phase III safety study of intravenous NEPA: A novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy

Lee Schwartzberg, E. Roeland, Z. Andric, D. Kowalski, J. Radic, D. Voisin, G. Rizzi, R. Navari, R. J. Gralla, M. Karthaus

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III safety study of intravenous NEPA: A novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences